Immunoprecipitation Market Research Report - Global Forecast till 2023

Global Immunoprecipitation Market Research Report: Information by Type (Individual Immunoprecipitation, Co-Immunoprecipitation, Chromatin Immunoprecipitation and RNA Immunoprecipitation), Product (Kit, Reagent, others), End-User (CROs, others) - Forecast till 2023

ID: MRFR/HC/6346-HCR | February 2021 | Region: Global | 90 pages

Market Scenario


Global Immunoprecipitation Market is expected to grow significantly over the forecast period. It is estimated that the global immunoprecipitation market is expected to hold a market value of USD 562 million and register a CAGR 5.2 % during the forecast period of 2018 to 2023. Immunoprecipitation is a method used for antigen purification and detection. It isolates a specific antigen from a mixture by using a specific antibody which is immobilized to a solid support such as, magnetic particles or agarose resin. An increasing number of research activities in the life sciences sector and growing need to identify antigens associated with autoimmune diseases are driving the market growth. According to the British Society of Immunology, more than 80 autoimmune diseases have been identified as of March 2016. Moreover, rising investments by governments and industries, growing biotechnology research across the globe, and increasing awareness about personalized therapeutics is fueling the market growth.


However, the presence of alternative technologies for protein purification may hamper market growth during the assessment period.


Key players in the market are involved in acquisitions, partnerships, and expansions. For instance, Thermo Fisher Scientific opened its new bioprocess design center in Shanghai to connect and collaborate with biologic developers to design optimal bioprocessing solutions in 2018.


Market Segmentation


The global immunoprecipitation market has been segmented into type, product, end user, and region.


The market, on the basis of type, has been segmented into individual immunoprecipitation, co-immunoprecipitation, chromatin immunoprecipitation, and RNA immunoprecipitation.


The market, by type, has been segmented into kit, reagent, and others.


The market, based on reagent, has been further segmented into antibodies and beads. Antibodies are further segmented into primary and secondary. Beads are further segmented into agarose beads, magnetic beads, and buffers.


The market, by end user, has been segmented into pharmaceutical & biotechnology companies, academic & research institutes, contract research organizations, and others.


The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The immunoprecipitation market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European immunoprecipitation market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The immunoprecipitation market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The immunoprecipitation market in the Middle East & Africa has been segmented into the Middle East and Africa.


Key Players



  • Abcam plc

  • GenScript

  • Thermo Fisher Scientific

  • Bio-Rad Laboratories, Inc.

  • Merck KGaA

  • BioLegend, Inc.

  • Takara Bio Inc.

  • Rockland Immunochemicals Inc.

  • Cell Signaling Technology, Inc.

  • Geno Technology Inc.


Immunoprecipitation Market Regional Summary


 Global Immunoprecipitation Market Share (%), by Region, 2017
 Immunoprecipitation Market


Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC)


Geographically, the Americas is anticipated to dominate the global immunoprecipitation market owing to the increasing research activities and the presence of major market players. Additionally, the well-developed healthcare sector is anticipated to boost the American immunoprecipitation market.


Europe is expected to hold the second-largest position in the global immunoprecipitation market. The market growth in this region is attributed to the availability of funds for research.


Asia-Pacific is anticipated to be the fastest-growing region in the market due to the growing investment from governments, growing biotechnology research in these regions, and raising awareness about personalized therapeutics. On the other hand, the Middle East & Africa is expected to account for the least share of the market. 


Global Immunoprecipitation Market, by Type



  • Individual Immunoprecipitation

  • Co-Immunoprecipitation

  • Chromatin Immunoprecipitation

  • RNA Immunoprecipitation


Global Immunoprecipitation Market, by Product



  • Kit

  • Reagent

    • Primary

    • Secondary

    • Agarose Beads

    • Magnetic Beads

    • Buffers

    • Antibodies

    • Beads

    • Others




Global Immunoprecipitation Market, by End User



  • Pharmaceutical & Biotechnology Companies

  • Academic & Research Institutes

  • Contract Research Organizations

  • Others


Global Immunoprecipitation Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • South America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • The Middle East & Africa

    • Middle East

    • Africa




 Intended Audience



  • Biotechnology Companies

  • Diagnostic Laboratories

  • Government Research Institutes

  • Academic Institutes and Universities



Frequently Asked Questions (FAQ) :


The global immunoprecipitation market is expected to hold a market valuation of USD 562 million over the forecast period from 2018 to 2023.

The global immunoprecipitation market is expected to exhibit a strong 5.2% CAGR over the forecast period from 2018 to 2023.

The increasing demand to find definitive cures for autoimmune and other immune diseases is the major driver for the market.

The Americas and Europe are likely to remain the dominant regional markets over the forecast period.

Leading players in the global immunoprecipitation market include GenScript, Merck, Bio-Rad, Thermo Fisher Scientific, and others.

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations
Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation
Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities
Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

Chapter 6. Global Immunoprecipitation Market, by Type

6.1 Introduction

6.2 Individual Immunoprecipitation

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.3 Co-Immunoprecipitation

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.4 Chromatin Immunoprecipitation

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.5 RNA Immunoprecipitation

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 7. Global Immunoprecipitation Market, by Product

7.1 Introduction

7.2 Kit

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Reagent

7.3.1 Antibodies

7.3.1.1 Primary

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3.1.2 Secondary

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3.2 Beads

7.3.2.1 Agarose Beads

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3.2.2 Magnetic Beads

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3.2.3 Buffers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.4 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023
Chapter 8. Global Immunoprecipitation Market, by End User

8.1 Introduction

8.2 Pharmaceutical & Biotechnology Companies

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3 Academic & Research Institutes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Contract Research Organizations

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.5 Others

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023
Chapter 9. Global Immunoprecipitation Market, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies
Chapter 11. Company Profiles

11.1 Abcam plc

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 GenScript

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 THERMO FISHER SCIENTIFIC

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Bio-Rad Laboratories, Inc.

11.4.1 Company Overview

11.4.2 Type Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Merck KGaA

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 BioLegend, Inc.

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 Takara Bio Inc.

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Rockland Immunochemicals Inc.

11.8.1 Overview

11.8.2 Type Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Cell Signaling Technology, Inc.

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.10 Geno Technology Inc.

11.10.1 Overview

11.10.2 Type Overview

11.10.3 Financials

11.10.4 Key Developments

11.10.5 SWOT Analysis
Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Immunoprecipitation Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Immunoprecipitation Market Synopsis, 2018–2023

Table 2 Global Immunoprecipitation Market Estimates and Forecast, 2018–2023 (USD Million)

Table 3 Global Immunoprecipitation Market, by Region, 2018–2023 (USD Million)

Table 4 Global Immunoprecipitation Market, by Type, 2018–2023 (USD Million)

Table 5Global Immunoprecipitation Market, by Product, 2018–2023 (USD Million)

Table 6 Global Immunoprecipitation Market, by End User, 2018–2023 (USD Million)

Table 7 North America: Immunoprecipitation Market, by Type, 2018–2023 (USD Million)

Table 8 North America: Immunoprecipitation Market, by Product, 2018–2023 (USD Million)

Table 9 North America: Immunoprecipitation Market, by End User, 2018–2023 (USD Million)

Table 10 US: Immunoprecipitation Market, by Type, 2018–2023 (USD Million)

Table 11 US: Immunoprecipitation Market, by Product, 2018–2023 (USD Million)

Table 12 US: Immunoprecipitation Market, by End User, 2018–2023 (USD Million)

Table 13 Canada: Immunoprecipitation Market, by Type, 2018–2023 (USD Million)

Table 14 Canada: Immunoprecipitation Market, by Product, 2018–2023 (USD Million)

Table 15 Canada: Immunoprecipitation Market, by End User, 2018–2023 (USD Million)

Table 16 South America: Immunoprecipitation Market, by Type, 2018–2023 (USD Million)

Table 17 South America: Immunoprecipitation Market, by Product, 2018–2023 (USD Million)

Table 18 South America: Immunoprecipitation Market, by End User, 2018–2023 (USD Million)

Table 19 Europe: Immunoprecipitation Market, by Type, 2018–2023 (USD Million)

Table 20 Europe: Immunoprecipitation Market, by Product, 2018–2023 (USD Million)

Table 21Europe: Immunoprecipitation Market, by End User, 2018–2023 (USD Million)

Table 22Western Europe: Immunoprecipitation Market, by Type, 2018–2023 (USD Million)

Table 23Western Europe: Immunoprecipitation Market, by Product, 2018–2023 (USD Million)

Table 24Western Europe: Immunoprecipitation Market, by End User, 2018–2023 (USD Million)

Table 25Eastern Europe: Immunoprecipitation Market, by Type, 2018–2023 (USD Million)

Table 26Eastern Europe: Immunoprecipitation Market, by Product, 2018–2023 (USD Million)

Table 27Eastern Europe: Immunoprecipitation Market, by End User, 2018–2023 (USD Million)

Table 28Asia-Pacific: Immunoprecipitation Market, by Type, 2018–2023 (USD Million) Table 29Asia-Pacific: Immunoprecipitation Market, by Product, 2018–2023 (USD Million)

Table 30 Asia-Pacific: Immunoprecipitation Market, by End User, 2018–2023 (USD Million)

Table 31Middle East & Africa: Immunoprecipitation Market, by Type, 2018–2023 (USD Million)

Table 32Middle East & Africa: Immunoprecipitation Market, by Product, 2018–2023 (USD Million)

Table 33Middle East & Africa: Immunoprecipitation Market, by End User, 2018–2023 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Market Structure for Global Immunoprecipitation Market

Figure 3 Market Dynamics for Global Immunoprecipitation Market

Figure 4 Global Immunoprecipitation Market Share, by Type, 2017

Figure 5 Global Immunoprecipitation Market Share, by Product, 2017

Figure 6 Global Immunoprecipitation Market Share, by End User, 2017

Figure 7 Global Immunoprecipitation Market Share, by Region, 2017

Figure 8 North America: Immunoprecipitation Market Share, by Country, 2017

Figure 9 Europe: Immunoprecipitation Market Share, by Country, 2017

Figure 10 Asia-Pacific: Immunoprecipitation Market Share, by Country, 2017

Figure 11 Middle East & Africa: Immunoprecipitation Market Share, by Country, 2017

Figure 12 Global Immunoprecipitation Market: Company Share Analysis, 2017 (%)

Figure 13 Abcam plc: Key Financials

Figure 14 Abcam plc: Segmental Revenue

Figure 15 Abcam plc: Geographical Revenue

Figure 16 GenScript: Key Financials

Figure 17 GenScript: Segmental Revenue

Figure 18 GenScript: Geographical Revenue

Figure 19 Thermo Fisher Scientific: Key Financials

Figure 20 Thermo Fisher Scientific: Segmental Revenue

Figure 21 Thermo Fisher Scientific: Geographical Revenue

Figure 22 Bio-Rad Laboratories, Inc.: Key Financials

Figure 23 Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 24 Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 25 Merck KGaA: Key Financials

Figure 26 Merck KGaA: Segmental Revenue

Figure 27 Merck KGaA: Geographical Revenue

Figure 28 BioLegend, Inc.: Key Financials

Figure 29 BioLegend, Inc.: Segmental Revenue

Figure 30 BioLegend, Inc.: Geographical Revenue

Figure 31 Takara Bio Inc.: Key Financials

Figure 32 Takara Bio Inc.: Segmental Revenue

Figure 33 Takara Bio Inc.: Geographical Revenue

Figure 34 Rockland Immunochemicals Inc.: Key Financials

Figure 35 Rockland Immunochemicals Inc.: Segmental Revenue

Figure 36 Rockland Immunochemicals Inc.: Geographical Revenue

Figure 37 Cell Signaling Technology, Inc.: Key Financials

Figure 38 Cell Signaling Technology, Inc.: Segmental Revenue

Figure 39 Cell Signaling Technology, Inc.: Geographical Revenue

Figure 40 Geno Technology Inc.: Key Financials

Figure 41 Geno Technology Inc.: Segmental Revenue

Figure 42 Geno Technology Inc.: Geographical Revenue




This table of content is tentative and subject to change as the research progresses.

Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.